Inflammation is a hallmark of the metabolic and cardiovascular condition known as diabetes. Nearly every cardiovascular risk factor is increased, and heart disease is the leading cause of death among diabetes. New opportunities for enhancing cardiovascular outcomes in diabetic patients have been opened up by recent advances in clinical research and patient education. The pathogenesis of diabetes and cardiovascular disease (CVD) is complicated. Clinicians can identify and treat CVD in diabetic patients with the help of an understanding of these complex disease processes, and patients can prevent potentially fatal consequences.

Cardiovascular conditions that affect diabetics and are not brought on by another recognised CVD, such as hypertension or coronary artery disease, are referred to as diabetic cardiomyopathy. Due to morphological and functional defects in diabetic cardiomyopathy, diabetes patients are predisposed to heart failure even early in the course of their disease.


  • Track 1-1 Diabetes and Cardiovascular Interaction
  • Track 2-2 Diabetes and Cardiovascular Disease
  • Track 3-3 Diabetes-Related Cardiomyopathy

Related Conference of Diabetes & Endocrinology